Literature DB >> 26541317

Potential of phage cocktails in the inactivation of Enterobacter cloacae--An in vitro study in a buffer solution and in urine samples.

S Pereira1, C Pereira1, L Santos1, J Klumpp2, A Almeida3.   

Abstract

The objective of this study was to compare the dynamics of three previously isolated phages for Enterobacter cloacae in order to evaluate their ability to treat urinary tract infections (UTI). The phages genomes, survival, host range, were characterized, and the host-phage dynamics was determined in culture medium and urine samples. The presence of prophages in bacteria, host recovery and development of resistance to phage after treatment was also evaluated. The growth of the E. cloacae was inhibited by the three phages, resulting in a decrease of ≈3 log. The use of cocktails with two or three phages was significantly more effective (decrease of ≈4 log). In urine, the inactivation was still effective (≈2 log). Both phages were considered safe to inactivate the bacteria (no integrase and toxin codifying genes). Some bacteria remained viable in the presence of the phages, but their colonies were smaller than those of the non-treated control and were visible only after 5 days of incubation (visible after 24h in the control). A high bacterial inactivation efficiency with phage cocktails combined with the safety of the phages and their long periods of survival, even in urine samples, paves the way for depth studies, especially in vivo studies, to control urinary tract infection and to overcome the development of resistances by the nosocomial bacterium E. cloacae.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bacterial-phage inactivation; Enterobacter cloacae; Multidrug resistant bacteria; Phage cocktails; Phenotypic resistance; Urinary tract infections

Mesh:

Year:  2015        PMID: 26541317     DOI: 10.1016/j.virusres.2015.10.025

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  10 in total

Review 1.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

Review 2.  State of the Art in the Culture of the Human Microbiota: New Interests and Strategies.

Authors:  Maryam Tidjani Alou; Sabrina Naud; Saber Khelaifia; Marion Bonnet; Jean-Christophe Lagier; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2020-10-28       Impact factor: 26.132

3.  Mining, analyzing, and integrating viral signals from metagenomic data.

Authors:  Tingting Zheng; Jun Li; Yueqiong Ni; Kang Kang; Maria-Anna Misiakou; Lejla Imamovic; Billy K C Chow; Anne A Rode; Peter Bytzer; Morten Sommer; Gianni Panagiotou
Journal:  Microbiome       Date:  2019-03-19       Impact factor: 14.650

4.  Efficiency of Phage φ6 for Biocontrol of Pseudomonas syringae pv. syringae: An in Vitro Preliminary Study.

Authors:  Larindja A M Pinheiro; Carla Pereira; Carolina Frazão; Victor M Balcão; Adelaide Almeida
Journal:  Microorganisms       Date:  2019-08-23

Review 5.  Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review.

Authors:  Krystyna Dąbrowska
Journal:  Med Res Rev       Date:  2019-03-19       Impact factor: 12.944

6.  Bystander Phage Therapy: Inducing Host-Associated Bacteria to Produce Antimicrobial Toxins against the Pathogen Using Phages.

Authors:  T Scott Brady; Christopher P Fajardo; Bryan D Merrill; Jared A Hilton; Kiel A Graves; Dennis L Eggett; Sandra Hope
Journal:  Antibiotics (Basel)       Date:  2018-12-04

Review 7.  Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.

Authors:  Zahra Chegini; Amin Khoshbayan; Soheil Vesal; Alireza Moradabadi; Ali Hashemi; Aref Shariati
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-04-26       Impact factor: 3.944

8.  Two Newly Isolated Enterobacter-Specific Bacteriophages: Biological Properties and Stability Studies.

Authors:  Martyna Cieślik; Marek Harhala; Filip Orwat; Krystyna Dąbrowska; Andrzej Górski; Ewa Jończyk-Matysiak
Journal:  Viruses       Date:  2022-07-12       Impact factor: 5.818

9.  Efficacy of diversely isolated lytic phages against multi-drug resistant Enterobacter cloacae isolates in Kenya.

Authors:  Ivy J Mutai; Angela A Juma; Martin I Inyimili; Atunga Nyachieo; Anthony K Nyamache
Journal:  Afr J Lab Med       Date:  2022-08-11

10.  In Vitro Design and Evaluation of Phage Cocktails Against Aeromonas salmonicida.

Authors:  Ling Chen; Shengjian Yuan; Quan Liu; Guoqin Mai; Jinfang Yang; Deng Deng; Bingzhao Zhang; Chenli Liu; Yingfei Ma
Journal:  Front Microbiol       Date:  2018-07-06       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.